Human Dermal Safety Studies with Eflornithine HCl 13.9% Cream (Vaniqa™), a Novel Treatment for Excessive Facial Hair

January 2000 in “ Current Medical Research and Opinion ”

Janet G. Hickman, Ferdinand Huber, Maria Palmisano

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on tandfonline.com →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

research Hirsutism

10 citations, May 1995 in “Journal of General Internal Medicine”

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

research Ornithine decarboxylase activity in relation to DNA synthesis in mouse interfollicular epidermis and hair follicles

34 citations, October 1975 in “Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis”

Related Research

2 / 2 results

research Safety Evaluation of Topical Valproate Application

6 citations, June 2013 in “Toxicological Research”

Topical Valproate is safe for human skin and unlikely to cause irritation.

research Human Dermal Safety Studies with Eflornithine HCl 13.9% Cream (Vaniqa™), a Novel Treatment for Excessive Facial Hair

3 citations, January 2000 in “Current Medical Research and Opinion”